Skip to content

Company information lookup


The Company is a clinical stage specialty pharmaceutical company focused on developing and commercialising therapies to treat disorders of the central nervous system.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
QRX 0.700 -7.28% 0.690 0.740 0.750 0.750 0.675 233,357


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code QRX
Official Listing Date 25 May, 2007
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address
Registered Office Address Level 11, Suite 1, 100 Walker Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Head Office Telephone (02) 8404 4139
Head Office Fax (02) 8920 0314
Share Registry Telephone 1300 554 474
Directors / Senior Management
Dr Peter Farrell (Chairman, Director)
Dr John Holaday (Managing Director, CEO, Director)
Mr Peter Campbell (Director)
Dr Gary Pace (Director)
Mr Michael Quinn (Director)
Mr Chris J Campbell (CFO)
Company Secretary Mr Chris J Campbell
Principal Activities The Company is a clinical stage specialty pharmaceutical company focused on developing and commercialising therapies to treat disorders of the central nervous system.

QRXPHARMA LTD announcements

How are company announcements published on

Date Price
Headline Pages PDF
24/03/2014   FDA sets 22 April 2014 for Moxduo Advisory Committee Meeting 2 PDF
10/03/2014   Appendix 3B - Exercise of Stock Options 11 PDF
25/02/2014   ASX / Media Release - Results Half Year 31 December 2013 2 PDF
25/02/2014 asterix Half Yearly Report and Accounts - 31 December 2013 19 PDF
30/01/2014   Appendix 3B - Exercise of Stock Options 11 PDF
29/01/2014 asterix Appendix 4C - Quarter Ended 31 December 2013 7 PDF
22/01/2014   Details of Company Address 1 PDF
17/12/2013   Holaday - Cease to be substantial holder 1 PDF
17/12/2013   Change of Director's Interest Notice - Peter Campbell 2 PDF
16/12/2013   QRxPharma Despatches SPP Holding Statements 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
15 Apr 2014 0.755 -3.21% 0.790 0.755 219,209
14 Apr 2014 0.780 -2.5% 0.800 0.770 219,896
11 Apr 2014 0.800 -4.76% 0.830 0.800 248,125
10 Apr 2014 0.840 1.2% 0.845 0.815 185,652
09 Apr 2014 0.830 6.41% 0.830 0.800 462,259

* Volume of shares shown represents only those shares traded on ASX.

QRXPHARMA LTD price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security QRX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security QRX

Warrants & Structured Products

No warrants & Structured Products are available over the security QRX


No Contracts For Differences are available over the security QRX